Gervasoni E, Cattaneo D, Messina P, et al. Clinical and stabilometric measures predicting falls in Parkinson disease/parkinsonisms. Acta Neurologica Scandinavica. 2015;132:235–241. DOI 10.1111/ane.12388
This note indexes a cited or audit-added source. It may be an original study, review, guideline, form or methods reference. Treat the specific design and the evidence below as authoritative; a source note is not automatically a primary study.
DOI: 10.1111/ane.12388
Bibliographic record from the original reports
Access labels embedded in these original reference strings are historical. Current access and exact checked components are stated separately below.
Gervasoni E, Cattaneo D, Messina P, et al. Clinical and stabilometric measures predicting falls in Parkinson disease/parkinsonisms. Acta Neurologica Scandinavica. 2015;132:235–241. DOI 10.1111/ane.12388
Conditions: COND-PD Parkinson’s disease
Scoped audit evidence
These are source- and component-level audit summaries as of 3 October 2026. Access and comparison scope can differ by report; none certifies every result or the underlying raw data.
Parkinson’s disease — balance
- access status: complete_original_PDF
Latest listed audit check, current for its stated components. Later recovery/refinement here supersedes earlier access limitations only where explicitly stated; it does not resolve unrelated source contradictions.
Complete original PDF independently supports revised balance P124–126 androwP160:53rehabpatients43PD/10parkinsonisms,H&Y2–4,previous-yearfall,7lost,46followed,32any22recurrent; four30secfirm/foamEO/EC conditions,24metrics->4PCAfactors,OR per factorunit. Methods explicitly describes LOOCV; sequencing of PCA/selection inside folds notspecified. Results p238 confirms LAPAQ anyfallAUC.718(.564–.872),sensitivity87.5/specificity35.7; recurrentFactor2OR2.37(1.01–5.58),p.0474,LAPAQp.0701 retained withP<.1; AUC.844(.716–.972),accuracy76.9,sensitivity77.8,specificity76.2. Original Table3 footnote visually confirms >=2falls versus nofalls, but single-faller handling/finaldenominator unclear. No externalvalidation/calibration or completeclinical-baseline comparison. Source locator: archived source evidence pp236–240,Tables1–4; audit evidence record Limit: The older version's label “apparent” should be replaced by “reported”; originalMethods describes LOOCV but doesnot distinguish apparent andvalidatedresults. Protocol omissions as described in report confirmed.
Earlier audit check 1 (historical evidence record). Its access limitations are superseded wherever the latest check above explicitly closes them. Retained for the distinct components and provenance, not as a current access statement.
Balance P124–126/P160 and olderP115–116/P146: abstract confirms53entered,7lost,46followed,32any22recurrent,6months,mixedPD/parkinsonisms,PCAvelocityfactorOR2.37(1.01–5.58),LAPAQanyfall significance,sens87.5/spec35.7;recurrentaccuracy76.9/sens77.8/spec76.2. Source locator: Official indexed abstract, archived source evidence Limit: 43PD/10other,rehab/history/HYcriteria,4x30protocol,24variables4factors,med/placement omissions,AUCs,CIs,p.0474/.0701,p<.1rule,LOOCV/nesting and Table3single-faller handling remain unverified without body. Accuracy denominator unresolved, not converted to an error.
Limitations: Only scoped comparisons, not whole-paper certification.
Parkinson’s disease — balance1
- access status: complete_original_PDF
Latest listed audit check, current for its stated components. Later recovery/refinement here supersedes earlier access limitations only where explicitly stated; it does not resolve unrelated source contradictions.
Complete original PDF independently supports revised balance P124–126 androwP160:53rehabpatients43PD/10parkinsonisms,H&Y2–4,previous-yearfall,7lost,46followed,32any22recurrent; four30secfirm/foamEO/EC conditions,24metrics->4PCAfactors,OR per factorunit. Methods explicitly describes LOOCV; sequencing of PCA/selection inside folds notspecified. Results p238 confirms LAPAQ anyfallAUC.718(.564–.872),sensitivity87.5/specificity35.7; recurrentFactor2OR2.37(1.01–5.58),p.0474,LAPAQp.0701 retained withP<.1; AUC.844(.716–.972),accuracy76.9,sensitivity77.8,specificity76.2. Original Table3 footnote visually confirms >=2falls versus nofalls, but single-faller handling/finaldenominator unclear. No externalvalidation/calibration or completeclinical-baseline comparison. Source locator: archived source evidence pp236–240,Tables1–4; audit evidence record Limit: The older version's label “apparent” should be replaced by “reported”; originalMethods describes LOOCV but doesnot distinguish apparent andvalidatedresults. Protocol omissions as described in report confirmed.
Earlier audit check 1 (historical evidence record). Its access limitations are superseded wherever the latest check above explicitly closes them. Retained for the distinct components and provenance, not as a current access statement.
Balance P124–126/P160 and olderP115–116/P146: abstract confirms53entered,7lost,46followed,32any22recurrent,6months,mixedPD/parkinsonisms,PCAvelocityfactorOR2.37(1.01–5.58),LAPAQanyfall significance,sens87.5/spec35.7;recurrentaccuracy76.9/sens77.8/spec76.2. Source locator: Official indexed abstract, archived source evidence Limit: 43PD/10other,rehab/history/HYcriteria,4x30protocol,24variables4factors,med/placement omissions,AUCs,CIs,p.0474/.0701,p<.1rule,LOOCV/nesting and Table3single-faller handling remain unverified without body. Accuracy denominator unresolved, not converted to an error.
Limitations: Only scoped comparisons, not whole-paper certification.
Linked audit findings
Reports citing this source
- Standing balance assessment and prognosis in Parkinson’s disease · reference 25 · original reference
- Standing balance assessment and prognosis in Parkinson’s disease · reference 7 · original reference
Update record
- 2026-10-03: Created from the supplied reports and final scoped audit. New evidence should be appended with source version, access date, exact locator and affected report links.
Updating the wiki · Evidence and status guide